IQVIA Holdings Inc
IQV156.890USD
-2.260-1.42%
Fechamento 06/13, 16:00（ET）Cotações atrasadas em 15 min
27.31BValor de mercado
19.89P/L TTM
Mais detalhes de IQVIA Holdings Inc Empresa
IQVIA Holdings Inc. is a global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. Its segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides mission-critical information, technology solutions and real-world insights and services to the Company’s life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers, and provides outsourced clinical research and clinical trial-related services. The Contract Sales & Medical Solutions segment provides healthcare provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. It offers a set of strategic and implementation consulting services, including advanced analytics and commercial processes outsourcing services.
Informações da empresa
Código da empresaIQV
Nome da EmpresaIQVIA Holdings Inc
Data de listagemMay 09, 2013
Fundado em2016
CEOMr. Ari Bousbib
Número de funcionários88000
Tipo de títulosOrdinary Share
Fim do ano fiscalMay 09
Endereço2400 Ellis Road
CidadeDURHAM
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal27703
Telefone19199982000
Sitehttps://ir.iqvia.com/
Código da empresaIQV
Data de listagemMay 09, 2013
Fundado em2016
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Ari Bousbib
Mr. Ari Bousbib
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.35M
+0.75%
Mr. Ronald E. (Ron) Bruehlman
Mr. Ronald E. (Ron) Bruehlman
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
46.46K
-1.91%
Mr. John G. Danhakl
Mr. John G. Danhakl
Independent Director
Independent Director
30.85K
-79.16%
Mr. Eric M. Sherbet
Mr. Eric M. Sherbet
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
21.11K
-0.84%
Ms. Colleen A. Goggins
Ms. Colleen A. Goggins
Independent Director
Independent Director
16.83K
+10.45%
Dr. John M. Leonard, M.D.
Dr. John M. Leonard, M.D.
Lead Independent Director
Lead Independent Director
15.38K
+11.55%
Ms. Carol J. Burt
Ms. Carol J. Burt
Independent Director
Independent Director
7.01K
+17.56%
Mr. James A. Fasano
Mr. James A. Fasano
Independent Director
Independent Director
2.74K
+157.67%
Mr. John P. Connaughton
Mr. John P. Connaughton
Independent Director
Independent Director
1.05K
--
Mr. Bhavik Patel
Mr. Bhavik Patel
President, Commercial Solutions
President, Commercial Solutions
947.00
-10.24%
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Ari Bousbib
Mr. Ari Bousbib
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.35M
+0.75%
Mr. Ronald E. (Ron) Bruehlman
Mr. Ronald E. (Ron) Bruehlman
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
46.46K
-1.91%
Mr. John G. Danhakl
Mr. John G. Danhakl
Independent Director
Independent Director
30.85K
-79.16%
Mr. Eric M. Sherbet
Mr. Eric M. Sherbet
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
21.11K
-0.84%
Ms. Colleen A. Goggins
Ms. Colleen A. Goggins
Independent Director
Independent Director
16.83K
+10.45%
Dr. John M. Leonard, M.D.
Dr. John M. Leonard, M.D.
Lead Independent Director
Lead Independent Director
15.38K
+11.55%
Detalhamento da receita
Moeda: USDAtualizado em: dom, 6 de abr
Moeda: USDAtualizado em: dom, 6 de abr
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Sem dados
Por RegiãoUSD
Nome
Receita
Proporção
Americas
7.36B
47.75%
Europe & Africa Region
4.92B
31.94%
Asia Pacific Region
3.13B
20.31%
Por Empresa
Por Região
Sem dados
Distribuição de ações
Atualizado em: sex, 16 de mai
Atualizado em: sex, 16 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
The Vanguard Group, Inc.
11.42%
Harris Associates L.P.
6.46%
BlackRock Institutional Trust Company, N.A.
5.71%
State Street Global Advisors (US)
4.46%
GIC Private Limited
3.78%
Other
68.16%
Investidores
Investidores
Proporção
The Vanguard Group, Inc.
11.42%
Harris Associates L.P.
6.46%
BlackRock Institutional Trust Company, N.A.
5.71%
State Street Global Advisors (US)
4.46%
GIC Private Limited
3.78%
Other
68.16%
Tipos de investidores
Investidores
Proporção
Investment Advisor/Hedge Fund
42.35%
Investment Advisor
32.92%
Hedge Fund
6.45%
Sovereign Wealth Fund
4.87%
Pension Fund
4.50%
Research Firm
2.35%
Bank and Trust
2.09%
Individual Investor
0.89%
Family Office
0.09%
Other
3.49%
Participação acionária institucional
Atualizado em: dom, 19 de jan
Atualizado em: dom, 19 de jan
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q1
2043
171.78M
99.27%
+6.16M
2024Q4
2059
171.87M
97.45%
+3.00M
2024Q3
2008
173.01M
95.44%
+863.78K
2024Q2
1977
164.85M
90.43%
-7.68M
2024Q1
1950
165.50M
90.84%
-10.38M
2023Q4
1948
168.90M
93.03%
-6.38M
2023Q3
1925
170.01M
92.82%
-4.41M
2023Q2
1898
167.84M
91.62%
-8.26M
2023Q1
1870
169.28M
91.24%
-7.20M
2022Q4
1852
168.30M
90.60%
-9.63M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
The Vanguard Group, Inc.
20.05M
11.37%
+108.12K
+0.54%
Dec 31, 2024
Harris Associates L.P.
11.34M
6.43%
+1.16M
+11.36%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
10.08M
5.72%
-49.64K
-0.49%
Dec 31, 2024
State Street Global Advisors (US)
7.88M
4.47%
+116.07K
+1.49%
Dec 31, 2024
GIC Private Limited
9.13M
5.18%
+9.13M
--
Aug 13, 2024
CPP Investment Board
4.28M
2.43%
+712.96K
+19.98%
Dec 31, 2024
Geode Capital Management, L.L.C.
4.18M
2.37%
+77.98K
+1.90%
Dec 31, 2024
AllianceBernstein L.P.
3.59M
2.04%
-298.60K
-7.67%
Dec 31, 2024
Farallon Capital Management, L.L.C.
3.12M
1.77%
-47.93K
-1.51%
Dec 31, 2024
Capital Research Global Investors
1.54M
0.87%
+3.19K
+0.21%
Dec 31, 2024
Ver Mais
ETFs Relacionados
Atualizado em: sex, 6 de jun
Atualizado em: sex, 6 de jun
Nome
Proporção
First Trust Nasdaq Lux Digi Health Solutions ETF
7.21%
Langar Global HealthTech ETF
5.66%
Global X HealthTech ETF
3.89%
VanEck Biotech ETF
3.6%
iShares Biotechnology ETF
2.34%
American Century Focused Large Cap Value ETF
2.11%
American Century Mid Cap Growth Impact ETF
2.05%
Invesco Zacks Mid-Cap ETF
1.65%
Running Oak Efficient Growth ETF
1.59%
Fidelity Digital Health ETF
1.58%
Ver Mais
First Trust Nasdaq Lux Digi Health Solutions ETF
Proporção7.21%
Langar Global HealthTech ETF
Proporção5.66%
Global X HealthTech ETF
Proporção3.89%
VanEck Biotech ETF
Proporção3.6%
iShares Biotechnology ETF
Proporção2.34%
American Century Focused Large Cap Value ETF
Proporção2.11%
American Century Mid Cap Growth Impact ETF
Proporção2.05%
Invesco Zacks Mid-Cap ETF
Proporção1.65%
Running Oak Efficient Growth ETF
Proporção1.59%
Fidelity Digital Health ETF
Proporção1.58%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
